
$Merck(MRK.US)起訴美國的《降低通脹法案》賦予醫療保險大幅降低老年人藥品價格的新權利是違憲,在沒有公正補償的情況下將私有財產用於公眾用途。原來在此法案下,強制規定藥物價格折扣 25 至 60%。藥廠利益大受影響。
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
